Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT01000714
NCT01000714
View on ClinicalTrials.gov
Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis
PHASE2
Completed
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Mild to Moderate Psoriasis
Interventions
DRUG
Psirelax
Trial Locations (1)
63564
Clalit Health care, Tel Aviv
All Listed Sponsors
lead
Etwal Ltd.
INDUSTRY
NCT01000714 - Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis | Biotech Hunter | Biotech Hunter